Article
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
JAMA neurology - 1 Dec 2023
Steward Anna, Biel Davina, Dewenter Anna, Roemer Sebastian, Wagner Fabian, Dehsarvi Amir, Rathore Saima, Otero Svaldi Diana, Higgins Ixavier, Brendel Matthias, Dichgans Martin, Shcherbinin Sergey, Ewers Michael, Franzmeier Nicolai
Abstract excerpt
Importance: For the Alzheimer disease (AD) therapies to effectively attenuate clinical progression, it may be critical to intervene before the onset of amyloid-associated tau spreading, which drives neurodegeneration and cognitive decline. Time points at which amyloid-associated tau spreading accelerates may depend on individual risk factors, such as apolipoprotein E ε4 (ApoE4) carriership, which is linked to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
